SEC Form 4 · accession 0001493152-18-015311
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. O'Connor
Officer — CEO & President · Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 7, 2018 · 12:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2018 | P | 10,000 | $0.91 | A | 26,667 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. O'Connor purchased 10,000 shares in the open market at a price of $0.91 per share.